Companies / United Kingdom
New GSK CEO Shakes Up Company Strategy
June 2008 | Company News AlertNew GlaxoSmithKline CEO Andrew Witty has put forward plans for the company's strategy, with a combination of more focused research strategies and a diversification of interests. Witty, who took up the role last month following the departure of Jean-Pierre Garnier, said this would reduce the risk of 'nasty surprises' for
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
